Max Coppes, Associate Director for Clinical Research, Renown Health’s William N. Pennington Cancer Institute, shared on LinkedIn:
”After nearly six incredibly rewarding years serving as Director of the William N. Pennington Cancer Institute (PCI), the time has come for me to devote more of my time, energy, and talents to family and friends.
Effective August 1, I will transition to a part-time role (0.6 FTE) as Associate Director of Clinical Research at PCI, an area about which I have always been deeply passionate. I remain deeply committed to our mission and look forward to expanding access to clinical research for the patients we serve while also having more time to share life’s important moments with family and friends.
Most importantly, I want to express my sincere gratitude to the remarkable PCI team. Any successes we have achieved over the past six years have been the result of your dedication, compassion, expertise, and unwavering commitment to the patients and families we serve. It has been an honor and privilege to work alongside such talented and caring professionals. Your partnership, friendship, and support have enriched my life and made this journey far more rewarding than I could have imagined.
It has been a privilege to be part of PCI’s growth and success, and I am excited to continue contributing in this new capacity. I look forward to supporting PCI’s continued excellence while embracing this next chapter with gratitude, optimism, and enthusiasm.”
Other articles about PCI on OncoDaily.